Partially circumventing peripheral tolerance for oncogene-specific prostate cancer immunotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/18302222

Prostate 2008 May 15 68 7 715-27

Download in:

View as

General Info

PMID
18302222